Literature DB >> 7565725

Collagenase expression in transgenic mouse skin causes hyperkeratosis and acanthosis and increases susceptibility to tumorigenesis.

J D'Armiento1, T DiColandrea, S S Dalal, Y Okada, M T Huang, A H Conney, K Chada.   

Abstract

In a series of transgenic mice, the human tissue collagenase gene was expressed in the suprabasal layer of the skin epidermis. Visually, the mice had dry and scaly skin which upon histological analysis revealed acanthosis, hyperkeratosis, and epidermal hyperplasia. At the ultrastructural level, intercellular granular materials were absent in the transgenic skin epidermis but contact was maintained through the intact desmosomes. Despite a diversity of underlying etiologies, similar morphological hyperproliferative changes in the epidermis are observed in the human skin diseases of lamellar ichthyosis, atopic dermatitis, and psoriasis. Subsequent experiments demonstrate that when the transgenic mouse skin was treated once with an initiator (7,12-dimethyl-benz[a]anthracene) and then twice weekly with a promoter (12-O-tetradecanoylphorbol-13-acetate), there was a marked increase in tumor incidence among transgenic mice compared with that among control littermates. These experiments demonstrate that by overexpressing the highly specific proteolytic enzyme collagenase, a cascade of events leading to profound morphological changes which augment the sensitivity of the skin towards carcinogenesis is initiated in the epidermis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7565725      PMCID: PMC230824          DOI: 10.1128/MCB.15.10.5732

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  31 in total

1.  Degradation of type I collagen by rat mucosal keratinocytes. Evidence for secretion of a specific epithelial collagenase.

Authors:  H Y Lin; B R Wells; R E Taylor; H Birkedal-Hansen
Journal:  J Biol Chem       Date:  1987-05-15       Impact factor: 5.157

2.  In vitro RNA synthesis with SP6 RNA polymerase.

Authors:  P A Krieg; D A Melton
Journal:  Methods Enzymol       Date:  1987       Impact factor: 1.600

3.  Constitutive production of procollagenase and tissue inhibitor of metalloproteinases by human keratinocytes in culture.

Authors:  M J Petersen; D T Woodley; G P Stricklin; E J O'Keefe
Journal:  J Invest Dermatol       Date:  1989-02       Impact factor: 8.551

4.  Use of bromodeoxyuridine-immunohistochemistry to examine the proliferation, migration and time of origin of cells in the central nervous system.

Authors:  M W Miller; R S Nowakowski
Journal:  Brain Res       Date:  1988-08-02       Impact factor: 3.252

5.  Alterations of cell surfaces as a pathogenetic factor in psoriasis. Possible loss of contact inhibition of growth.

Authors:  C E Orfanos; G Schaumburg-Lever; G Mahrle; W F Lever
Journal:  Arch Dermatol       Date:  1973-01

6.  Efficient in vitro synthesis of biologically active RNA and RNA hybridization probes from plasmids containing a bacteriophage SP6 promoter.

Authors:  D A Melton; P A Krieg; M R Rebagliati; T Maniatis; K Zinn; M R Green
Journal:  Nucleic Acids Res       Date:  1984-09-25       Impact factor: 16.971

7.  Human alveolar macrophages produce a fibroblast-like collagenase and collagenase inhibitor.

Authors:  H G Welgus; E J Campbell; Z Bar-Shavit; R M Senior; S L Teitelbaum
Journal:  J Clin Invest       Date:  1985-07       Impact factor: 14.808

8.  Production of procollagenase by cultured human keratinocytes.

Authors:  M J Petersen; D T Woodley; G P Stricklin; E J O'Keefe
Journal:  J Biol Chem       Date:  1987-01-15       Impact factor: 5.157

9.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.

Authors:  J M Chirgwin; A E Przybyla; R J MacDonald; W J Rutter
Journal:  Biochemistry       Date:  1979-11-27       Impact factor: 3.162

Review 10.  Chemical induction of oncogene mutations and growth factor activity in mouse skin carcinogenesis.

Authors:  B Bailleul; K Brown; M Ramsden; R J Akhurst; F Fee; A Balmain
Journal:  Environ Health Perspect       Date:  1989-05       Impact factor: 9.031

View more
  29 in total

1.  Upregulation of tyrosine kinase TKT by the Epstein-Barr virus transactivator Zta.

Authors:  J Lu; S Y Chen; H H Chua; Y S Liu; Y T Huang; Y Chang; J Y Chen; T S Sheen; C H Tsai
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

Review 2.  How matrix metalloproteinases regulate cell behavior.

Authors:  M D Sternlicht; Z Werb
Journal:  Annu Rev Cell Dev Biol       Date:  2001       Impact factor: 13.827

Review 3.  Matrix metalloproteinase inhibitors.

Authors:  Nithya Ramnath; Patrick J Creaven
Journal:  Curr Oncol Rep       Date:  2004-03       Impact factor: 5.075

4.  Basic fibroblast growth factor: a missing link between collagen VII, increased collagenase, and squamous cell carcinoma in recessive dystrophic epidermolysis bullosa.

Authors:  J L Arbiser; J D Fine; D Murrell; A Paller; S Connors; K Keough; E Marsh; J Folkman
Journal:  Mol Med       Date:  1998-03       Impact factor: 6.354

5.  Pathophysiology of Emphysema and Implications.

Authors:  Monica Goldklang; Robert Stockley
Journal:  Chronic Obstr Pulm Dis       Date:  2016-01-15

6.  Epidermal growth factor receptor signaling is partially responsible for the increased matrix metalloproteinase-1 expression in ocular epithelial cells after UVB radiation.

Authors:  Nick Di Girolamo; Minas Coroneo; Denis Wakefield
Journal:  Am J Pathol       Date:  2005-08       Impact factor: 4.307

Review 7.  Nuclear hormone receptors inhibit matrix metalloproteinase (MMP) gene expression through diverse mechanisms.

Authors:  D J Schroen; C E Brinckerhoff
Journal:  Gene Expr       Date:  1996

8.  Loss of JunB activity enhances stromelysin 1 expression in a model of the epithelial-to-mesenchymal transition of mouse skin tumors.

Authors:  D L Hulboy; L M Matrisian; H C Crawford
Journal:  Mol Cell Biol       Date:  2001-08       Impact factor: 4.272

9.  Inhibition of 7,12-dimethylbenzanthracene-induced skin tumors by a nutrient mixture.

Authors:  M W Roomi; N W Roomi; T Kalinovsky; V Ivanov; M Rath; A Niedzwiecki
Journal:  Med Oncol       Date:  2008-01-18       Impact factor: 3.064

10.  Site controlled transgenic mice validating increased expression from human matrix metalloproteinase (MMP-1) promoter due to a naturally occurring SNP.

Authors:  Charles I Coon; Steven Fiering; Justin Gaudet; Colby A Wyatt; Constance E Brinckerhoff
Journal:  Matrix Biol       Date:  2009-07-03       Impact factor: 11.583

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.